search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Received: 22 April 2023 | Accepted: 5 June 2023 DOI: 10.1111/eve.13848


OR IG INA L A R T I C L E


Strongyle egg reappearance periods following moxidectin treatment in horses in Southeast England


Tim S. Mair 1 | Rebecca Opie 1 | Michelle Moreton- Clack 1 | Tim D. Parkin 2 Jacqui B. Matthews 3


1 CVS Group PLC , Bell Equine Veterinary Clinic , Mereworth, Kent , UK 2 Bristol Veterinary School , University of Bristol , Langford , UK 3 Austin Davis Biologics Ltd , Great Addington , UK


Correspondence : Tim S. Mair Email: tim.mair@btinternet.com


Abstract Background : A reduction in the egg reappearance period (ERP) has been suggested to be an early indication of emerging anthelmintic resistance in strongyles. Objective : To measure the strongyle ERP following moxidectin treatment of horses in the southeast of England. Study design : Prospective study. Methods : Horses with a faecal egg count (FEC) of ≥400 strongyle eggs per gram (EPG) in a routine screening sample were enrolled into the study. Moxidectin (400 μg/kg) was administered per os and FEC tests repeated every 2 weeks for 16 weeks. Results : Forty- eight horses completed the study. The mean EPG prior to treatment was 1047 (range 375– 2137 EPG). In all but two horses, FEC was 0 EPG 2 weeks after mox- idectin administration. In the remaining two, the FECs were each 12.5 EPG (97.8%– 98.3% reductions compared to pre- treatment FEC). At 4 weeks post- treatment, 6 horses had positive FECs (96.6%– 99.2% reductions). At 6 weeks, 11 horses had positive FECs (83.8% reduction in one horse; >90% reduction in 10). At 8 weeks, 21 horses exhibited positive FECs (<90% reduction in 2). At 10 weeks, 27 horses had positive FECs (<90% in 6). At 12 weeks, 31 horses had positive FECs (<90% reduction in 11). At 14 weeks, 34 horses had positive FECs (<90% reduction in 13). At 16 weeks, 38 horses had positive FECs (<90% reduction in 17). Main limitations : Weights of some horses were estimated using weigh tapes rather than a weighbridge. Dosing of the horses with moxidectin was carried out by owners. Conclusions : The results indicated acceptable efficacy of moxidectin at 14 days after treatment; however, the ERP pattern measured across the group suggests that this an- thelmintic has a considerably shorter suppressive effect on strongyle egg shedding than measured when it was first introduced (12– 16 weeks).


K E YWORDS horse , anthelmintic resistance , egg reappearance period , moxidectin


|


INTRODUCTION


Grazing horses are constantly exposed to parasites, with the cy- athostomins


(“small © 2023 EVJ Ltd. redworms”)


being the commonest. These parasitic nematodes encompass >40 36 |


(Strongylida: Cyathostominae)


species in 14 genera, but coinfections with 15– 25 species are most common (Bellaw & Nielsen, 2020 ). Current recommendations for cyathostomin control are aimed at reducing the risk of pasture con- tamination and minimising the chances of disease caused by the par- asites (Matthews, 2000 , 2011 ; Rendle et al., 2019 ) using strategic or


aaep.org/wiley-redirect Equine Vet Educ. 2024;36:36–41.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76